-
Bryan Xavier replied to the topic "Allergan's BIOCELL Breast Implant Recall: A Case Study in Quality and Risk Management" – 1 week, 2 days ago
I agree that regulatory approval shouldn’t be the end all be all for safety. There are multiple strategies that companies can and should take before a product hits the market. One such method is a Failure Modes and Effect Analysis,… Read more»